BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16732286)

  • 1. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.
    Barton WA; Tzvetkova-Robev D; Miranda EP; Kolev MV; Rajashankar KR; Himanen JP; Nikolov DB
    Nat Struct Mol Biol; 2006 Jun; 13(6):524-32. PubMed ID: 16732286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.
    Barton WA; Tzvetkova D; Nikolov DB
    Structure; 2005 May; 13(5):825-32. PubMed ID: 15893672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.
    Davis S; Papadopoulos N; Aldrich TH; Maisonpierre PC; Huang T; Kovac L; Xu A; Leidich R; Radziejewska E; Rafique A; Goldberg J; Jain V; Bailey K; Karow M; Fandl J; Samuelsson SJ; Ioffe E; Rudge JS; Daly TJ; Radziejewski C; Yancopoulos GD
    Nat Struct Biol; 2003 Jan; 10(1):38-44. PubMed ID: 12469114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.
    Bogdanovic E; Nguyen VP; Dumont DJ
    J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2.
    Wu X; Zhao R; Li Z; Yao M; Wang H; Han J; Qu S; Chen X; Qian L; Sun Y; Xu Y; Gu J
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1004-10. PubMed ID: 14985112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
    Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
    Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for angiopoietin-1-mediated signaling initiation.
    Yu X; Seegar TC; Dalton AC; Tzvetkova-Robev D; Goldgur Y; Rajashankar KR; Nikolov DB; Barton WA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7205-10. PubMed ID: 23592718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
    Shlamkovich T; Aharon L; Barton WA; Papo N
    Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap.
    Bate N; Lodge J; Brindle NPJ
    J Biol Chem; 2021 Aug; 297(2):100888. PubMed ID: 34153320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.
    Yacyshyn OK; Lai PF; Forse K; Teichert-Kuliszewska K; Jurasz P; Stewart DJ
    Angiogenesis; 2009; 12(1):25-33. PubMed ID: 19116766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tie2 expression by angiopoietin--potential feedback system.
    Hashimoto T; Wu Y; Boudreau N; Li J; Matsumoto M; Young W
    Endothelium; 2004; 11(3-4):207-10. PubMed ID: 15370298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
    Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
    Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning.
    Ward NL; Van Slyke P; Dumont DJ
    Biochem Biophys Res Commun; 2004 Oct; 323(3):937-46. PubMed ID: 15381091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SpTie1/2 is expressed in coelomocytes, axial organ and embryos of the sea urchin Strongylocentrotus purpuratus, and is an orthologue of vertebrate Tie1 and Tie2.
    Stevens ME; Dhillon J; Miller CA; Messier-Solek C; Majeske AJ; Zuelke D; Rast JP; Smith LC
    Dev Comp Immunol; 2010 Aug; 34(8):884-95. PubMed ID: 20363251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.
    Moore JO; Lemmon MA; Ferguson KM
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4382-4387. PubMed ID: 28396397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Angiopoietins in vascular morphogenesis.
    Thomas M; Augustin HG
    Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.